Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
GSK Ware Manufacturing Site in the United Kingdom seeks a strategic on-site technology leader to advance AI-enabled Smart Manufacturing initiatives. You will embed into site and business teams to rapidly translate high-priority opportunities into working PoCs, PoVs and MVPs, using real data and workflows.
Lead engineering across AI, data, integration and automation while ensuring governance and lifecycle ownership.
This is a new strategic role aimed at providing on-site technology expertise, leadership, product engagement, and delivery support for GSK's key manufacturing sites. The role acts as the interface between local business stakeholders and global digital product teams. It embeds directly into the site and business teams to rapidly translate high-priority Smart Manufacturing and AI opportunities into working Proof of Concept (PoC), Proof of Value (PoV), and Minimum Viable Product (MVP).
As the technical specialist you will apply AI-native engineering methods to validate business value, technical feasibility and governance requirements to provide evidence-based stop-or-continue recommendations, through to proven solutions to product teams (for production scale-up and lifecycle management).
This role would suit a highly motivated person who has strong experience of designing, developing, and validating AI-enabled digital solutions and Smart Manufacturing capabilities within complex manufacturing and business environments. You will have strong technical knowledge obtained from working in a highly-regulated industry. You will have demonstrably strong people skills, be resilient and calm under pressure, have a strong continuous improvement mindset, and a proven ability to drive performance while managing multiple stakeholders.
Medicines at Ware are presented as either Respiratory devices or in Oral Solid Dose form. The site holds a unique position in our network as the only site responsible for launching the company's pipeline of new medicines in these dose forms, many of which are life saving medicines. A series of investments in new state-of-the-art equipment are being made that will support the delivery of a record number of new products.
CLOSING DATE for applications: Monday 30 th of November 2026 (COB).
We